Matthew Vander Heiden Named Editor-in-Chief of Cancer Discovery 2026

New Leadership for a Leading Cancer Research Journal

The American Association for Cancer Research (AACR) has appointed Matthew Vander Heiden, MD, PhD, FAACR, as the new editor-in-chief of Cancer Discovery, one of its leading scientific journals.

• Matthew Vander Heiden: Director of the Koch Institute for Integrative Cancer Research at MIT, Professor of Biology and Lester Wolfe Professor of Molecular Biology at MIT, and an oncologist at Dana-Farber Cancer Institute and Harvard Medical School.
• Luis A. Diaz, Jr., MD, FAACR: Served as editor-in-chief since 2019 and will continue to contribute alongside Vander Heiden.

Cancer Discovery publishes original research and reviews covering various aspects of cancer research, including laboratory science, clinical medicine, epidemiology, and population-based studies. It aims to disseminate influential research during a period of rapid scientific progress.

About the Role

Matthew Vander Heiden will lead Cancer Discovery alongside Luis A. Diaz, Jr., MD, FAACR, bringing his expertise in cancer metabolism, translational research, and institutional leadership to the journal.

Responsibilities

• Supporting the publication of influential cancer research.
• Bringing together findings from across the cancer research community.
• Communicating discoveries with clarity to improve outcomes for patients worldwide.

Qualifications

• Extensive experience in cancer metabolism, translational research, clinical oncology, and institutional leadership.
• Contributions to the AACR, including serving as chair of the AACR Annual Meeting Program Committee and co-chairing the AACR Special Virtual Conference on Epigenetics and Metabolism.
• Recognition across the scientific community, including the National Cancer Institute Outstanding Investigator Award and the AACR Gertrude B. Elion Cancer Research Award.

Skills

• Expertise in cancer metabolism and translational research.
• Leadership experience in cancer centers and institutions.
• Ability to communicate complex scientific findings clearly.

Benefits

Cancer Discovery benefits from the combined leadership of Matthew Vander Heiden and Luis A. Diaz, Jr., MD, FAACR, ensuring continued excellence in disseminating influential cancer research.

Pay

The pay details for this position are not specified in the provided information.

Schedule

The schedule for this position is not specified in the provided information.